Litcius/Paper detail

Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT

Édouard Forcade, Sylvie Chevret, Jürgen Finke, Gerhard Ehninger, Francis Ayuk, Dietrich W. Beelen, Linda Köster, Arnold Ganser, Liisa Volin, Henrik Sengeloev, Mauricette Michallet, Johanna Tischer, Pavel Jindra, María Jesús Pascual Cascón, Yener Koç, Mutlu Arat, Agnieszka Tomaszewska, Patrick Hayden, Théo de Witte, Ibrahim Yakoub‐Agha, Nicolaus Kröger, Marie Robin

2022Bone Marrow Transplantation18 citationsDOI

Topics & Concepts

AlemtuzumabMedicineInternal medicineCD52OncologyHematopoietic stem cell transplantationCumulative incidenceGastroenterologyGraft-versus-host diseaseSurgeryImmunologyTransplantationAcute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationChronic Myeloid Leukemia Treatments
Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT | Litcius